Share on StockTwits

Stock analysts at Cowen and Company reduced their target price on shares of Express Scripts Holding Company (NASDAQ:ESRX) from $77.00 to $76.00 in a report issued on Thursday. The firm currently has a “market perform” rating on the stock. Cowen and Company’s price objective points to a potential upside of 8.31% from the stock’s previous close.

Express Scripts Holding Company (NASDAQ:ESRX) traded up 0.75% during mid-day trading on Thursday, hitting $70.17. 5,266,499 shares of the company’s stock traded hands. Express Scripts Holding Company has a 1-year low of $59.20 and a 1-year high of $79.37. The stock has a 50-day moving average of $68.22 and a 200-day moving average of $71.86. The company has a market cap of $52.308 billion and a price-to-earnings ratio of 31.12.

Express Scripts Holding Company (NASDAQ:ESRX) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.01. The company had revenue of $25.11 billion for the quarter, compared to the consensus estimate of $24.42 billion. During the same quarter in the previous year, the company posted $1.12 earnings per share. The company’s revenue for the quarter was down 4.8% on a year-over-year basis. Analysts expect that Express Scripts Holding Company will post $4.87 EPS for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Express Scripts Holding Company in a research note on Wednesday. They now have a $71.00 price target on the stock. Separately, analysts at Jefferies Group cut their price target on shares of Express Scripts Holding Company from $86.00 to $80.00 in a research note on Wednesday. They now have a “buy” rating on the stock. Finally, analysts at FBR Capital Markets reiterated an “outperform” rating on shares of Express Scripts Holding Company in a research note on Wednesday, July 23rd. They now have a $74.00 price target on the stock, down previously from $79.00. Four analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $79.78.

Express Scripts, Inc is a pharmacy benefit management (NASDAQ:ESRX) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.